Netherlands· NL-e301e97df829

Bemrist Breezhaler 125 microgram/260 microgram inhalatiepoeder in harde capsules

A indacaterol und mometason product containing mometasonfuroaat, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AK14

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mometasonfuroaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Indacaterol und mometason is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AK14 (indacaterol und mometason), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search indacaterol und mometason products by name

Indacaterol und mometason · ATC R03AK14

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of indacaterol und mometason costs, country by country.

Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Indacaterol und mometason · price per daily dose (0.15 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.85

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MOMETASONFUROAAT
Manufacturer: Novartis Europharm Limited
Country: Netherlands (NL)
ATC code: R03AK14
ATC class: Indacaterol und Mometason
Defined daily dose: 0.15 mg, Inhal
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/20/1441

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Indacaterol und mometason in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indacaterol und mometason products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Asmanex Twisthaler, Elocon
Belgium · Asmanex Twisthaler, Elocom
Bulgaria · Блоктимо, Елоком
Cyprus · Elocon, Movesan
Czechia · Asmanex, Elocom
Germany · Allergo-Momelind, Asmanex Twisthaler
Denmark · Aphiahsone, Asmanex Twisthaler
Estonia · Breso, Elocon
Spain · Asmanex Twisthaler, Elocom
Finland · Asmanex Twisthaler, Demoson
France · Asmanex Twisthaler, Mometasone Arrow
United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
Greece · Asmanex Twisthaler, Elocon
Croatia · Elocom, Momanose
Hungary · Azocutan, Elocom
Ireland · Asmanex Twisthaler, Elocon
Iceland · Elocon, Kalmente
Italy · Arinit, Asmanex
Lithuania · Breso, Elocon
Luxembourg · Elocom, Monovo
Latvia · Breso, Elocon
Malta · Elocon, Nasonex
Norway · Asmanex Twisthaler, Elocon
Poland · Aleric Spray, Edelan
Portugal · Asmanex Twisthaler, Desdek
Romania · Elocom, Furoat De Mometazonă Cipla
Sweden · Aphiahsone, Asmanex Twisthaler
Slovenia · Asmanex Twisthaler, Elocom
Slovakia · Asmanex, Elocom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bb7a93c4-ce14-4627-a765-c754ac96caa7
GET /v1/drugs/bb7a93c4-ce14-4627-a765-c754ac96caa7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalatiepoeder in harde capsule",
  "route": "Inhalatie",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/bemrist-breezhaler-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Indacaterol and mometasone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp125915",
  "excipients": [
    "AMMONIA (E 527)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "INDACATEROLACETAAT",
    "LACTOSE 1-WATER",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "ZWARTE INKT"
  ],
  "substances": [
    "MOMETASONFUROAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/05/30",
  "procedure_number": "EMEA/H/C/005516",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1441",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about indacaterol und mometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console